Corium International Inc. | Mutual Funds
Mutual Funds that own Corium International Inc.
Franklin Small Cap Growth Fund
851,750
2.35%
0
0.28%
03/31/2018
Vanguard Total Stock Market Index Fund
805,223
2.22%
0
0%
07/31/2018
FTIF SICAV - Franklin Biotechnology Discovery Fund
649,200
1.79%
0
0.27%
06/30/2018
iShares Russell 2000 ETF
559,616
1.54%
-300
0.01%
09/06/2018
iShares Nasdaq Biotechnology ETF
415,010
1.14%
-5,418
0.04%
09/06/2018
Vanguard Extended Market Index Fund
363,601
1%
0
0.01%
07/31/2018
Franklin Biotechnology Discovery Fund
350,800
0.97%
350,800
0.24%
03/31/2018
HBM BioVentures Ltd.
334,323
0.92%
21,266
0.22%
12/31/2017
iShares Russell 2000 Growth ETF
237,061
0.65%
0
0.02%
09/06/2018
Royce Low Priced Stock Fund
218,300
0.6%
218,300
0.75%
06/30/2018
| Address |
235 Constitution Drive
Menlo Park California 94025
United States
|
|
Employees
|
- |
| Website |
http://www.coriumgroup.com |
| Updated |
09/14/2018 |
| Corium International, Inc. is a commercial stage biopharmaceutical company, which develops, manufactures and commercializes pharmaceutical products. The company development platforms enable transdermal delivery of large molecules or biologics, including vaccines, peptides and proteins, as well as small molecules that are otherwise difficult to deliver in a transdermal dosage form. The firm offers its products under the brands Corplex and MicroCor. |
